Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Research Area(s) / Expertise: Job title: Cardiologist
Dr Michel Komajda is a Cardiologist at theNational Academy of Medicine in Paris, France.He is a past president of the European Society of Cardiology and the French Cardiac Society.He has been a member of the steering comittee, clinical endpoint committee or DSMB of many notable heart failure clinical trials, including SHIFT, CORONA, I PRESERVE, COMET, PARADIGM HF, CARMEN, EMPHESUS, RENAISSANCE,… View more
Re-Evaluating GDMT in Heart Failure
Author(s): Gianluigi Savarese , Orly Vardeny , Biykem Bozkurt Added: 2 years ago
This video series is dedicated to re-evaluating guideline-directed medical therapy (GDMT) in patients with heart failure (HF). Spilt into two short videos, in the first partDr Gianluigi Savarese (Karolinska Institute, Stockholm, SE) and Dr Biykem Bozkurt (Baylor College of Medicine, Texas, US) discuss the most recent changes to clinical practice guidelines and consider the clinical trial… View more

Heart Failure
Incorporating GDMT and PRO Endpoints for Personalised HF Management
Author(s): Mikhail Kosiborod , Shelley Zieroth , Andrew JS Coats , et al Added: 2 years ago
This series of peer-to-peer discussions examines the practicalities of personalising heart failure management in the context of recent changes to international clinical practice guidelines. At this exciting juncture, we now have two SGLT-2 inhibitors that offer clinical benefit across the spectrum of ejection fraction, and an increasing body of real-world and registry-based data showing… View more

Heart Failure
Mineralocorticoid Receptor Antagonists in Heart Failure
Author(s): Rishi Sethi , Pravesh Vishwakarma , Akshyaya Pradhan Added: 5 months ago

Heart Failure

MI/ACS